Apellis Pharmaceuticals, Inc.
(NASDAQ : APLS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc. -0.84%40.460.9%$2323.99m
JNJJohnson & Johnson 0.66%149.120.7%$1163.14m
ABBVAbbVie, Inc. 0.20%105.201.9%$1036.33m
MRKMerck & Co., Inc. -0.16%81.700.7%$708.08m
BMYBristol-Myers Squibb Co. -0.19%62.061.0%$685.82m
LLYEli Lilly & Co. -0.22%144.841.1%$659.48m
AZNAstraZeneca Plc -1.27%52.711.2%$365.44m
TTNPTitan Pharmaceuticals, Inc. 3.13%3.620.6%$286.38m
GSKGlaxoSmithKline Plc -0.15%37.350.2%$227.74m
NVSNovartis AG -1.23%90.450.2%$202.14m
ARCTArcturus Therapeutics Holdings, Inc. 17.62%97.980.0%$119.74m
RGENRepligen Corp. 0.44%187.837.1%$98.17m
NVONovo Nordisk A/S -1.06%67.420.1%$90.61m
RPRXRoyalty Pharma Plc 0.81%42.120.2%$82.33m
CVACCureVac NV -0.17%102.490.0%$71.66m

Company Profile

Apellis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which develops novel therapeutic compounds. It develops complement immunotherapies for the treatment of complement-dependent autoimmune and inflammatory diseases through APL-2 product. The company was founded by Candace Rose Depp, Pascal Deschatelets, Cedric Francois, Alec Machiels on September 25, 2009 and is headquartered in Waltham, MA.